Diabetes and Insurance

Abstract

India has healthcare expenditure of more than 5 billion dollars on diabetes-related healthcare management. Globally, approximately 12% of health expenditure is spent on diabetes and related comorbidities. Hospitalization includes hospital and laboratory expenses and cost of medications as the direct cost. India is among the countries, where if the insured dies during the time period specified in the insurance policy and the policy is active, or in force, then a death benefit will be paid. Studies in India reported that medical reimbursement is availed by 21.3% in the high-income group and only 6.4% of the urban low-income group. An average cost of management of diabetic complications like diabetic foot, retinopathy, and patients with two complications was almost close to the average cost of claimed amount. Patients may be advised to take insurance for diabetes when there is any indication of future disease and risk factors contributing to diabetes like a strong family history, obesity, hypertension, and other vascular diseases. Diabetes Safe from Star Health and Varistha Mediclaim from National Insurance were among the first insurance policies to be launched in India.

Keywords

healthcare expenditure - financial burden - term versus life insurance - healthcare education

Publikationsverlauf

Artikel online veröffentlicht:
30. März 2020

• References

• 1 Executive summary. In: IDF Diabetes Atlas. 8th ed. 2017
• 2 Ramachandran A, Ramachandran S, Snehalatha C. et al. Increasing expenditure on health care incurred by diabetic subjects in a developing country: a study from India. Diabetes Care 2007; 30 (02) 252-256
• 3 Viswanathan V, Rao VN. Problems associated with diabetes care in India. Diabetes Manage 2013; 3 (01) 31-40
• 4 Tharkar S, Devarajan A, Kumpatla S, Viswanathan V. The socioeconomics of diabetes from a developing country: a population based cost of illness study. Diabetes Res Clin Pract 2010; 89 (03) 334-340
• 5 Smith-Spangler CM, Bhattacharya J, Goldhaber-Fiebert JD. Diabetes, its treatment, and catastrophic medical spending in 35 developing countries. Diabetes Care 2012; 35 (02) 319-326
• 6 Yesudian CAK, Grepstad M, Visintin E, Ferrario A. The economic burden of diabetes in India: a review of the literature. Global Health 2014; 10 (80) 80
• 7 La Forgia G, Nagpal S. Government-Sponsored Health Insurance in India: Are You Covered? Directions in Development. Washington, DC: World Bank 2012
• 8 WHO. World Health Survey: current status of the World Health Survey. Available at: www.who.int/healthinfo/survey/en/index. html. Accessed March 30, 2017)
• 9 Kapur A. Economic analysis of diabetes care. Indian J Med Res 2007; 125 (03) 473-482
• 10 Makers T. In Partnership with Economictimes.com [Internet]. Bengaluru: Why you should get diabetes insurance before it is too late. Available at: http://economictimes.indiatimes.com/wealth/insure/why-you-should-get-diabetes-insurance-before-it-is-too-late/articleshow/55451789.cms. Accessed November 21, 2019
• 11 Kumpatla S, Kothandan H, Tharkar S, Viswanathan V. The costs of treating long-term diabetic complications in a developing country: a study from India. J Assoc Physicians India 2013; 61 (02) 102-109
• 12 The Economic Times. Insure [Internet]. ET Bureau. Why you may need diabetes insurance. Available at: http://economictimes.indiatimes.com/wealth/insure/why-you-may-need-diabetes-insurance/articleshow/51753474.cms. Accessed March 26, 2017